BioCentury | Dec 20, 2010
Strategy

TAP's Big Finish

...for multiple undisclosed antigens Ended in 2006 Up to $30M up front and milestones 2001 Eos Biotechnology Inc....
BioCentury | Jul 23, 2007
Company News

Crucell management update

...SVP of R&D at CRXL's newly formed protein business unit, formerly chief technical officer at Eos Biotechnology Inc....
BioCentury | Jan 22, 2007
Strategy

Reset button

...his early promises. He had added biology expertise with the 2003 acquisition of antibody company Eos Biotechnology Inc....
BioCentury | Aug 29, 2005
Strategy

Tracking PDLI

...drops development of SMART anti-IL-12 antibody and Remitogen apolizumabC. 2/4/03 - Announces plans to acquire Eos Biotechnology...
BioCentury | Aug 29, 2005
Strategy

Thinking commercial

...in the hospital channel." McDade addressed the research gap in his first deal - acquiring Eos Biotechnology Inc....
BioCentury | Jun 27, 2005
Company News

Genentech, Protein Design Labs sales and marketing update

...milestones and royalties. Under a 2004 deal between Seattle Genetics Inc. (SGEN, Bothell, Wash.) and Eos Biotechnology...
BioCentury | Jan 31, 2005
Strategy

A NRDO exits

...still here. We are hoping to do the same with ESP." PDLI bought antibody company Eos Biotechnology Inc....
BioCentury | Sep 13, 2004
Company News

Arriva management update

...Robert Williamson as CEO, formerly an advisor to Arriva, and previously president and COO at Eos Biotechnology Inc....
BioCentury | Sep 9, 2004
Company News

Arriva names Williamson CEO

...most recently was an advisor to Arriva . Previously, he was president and COO at Eos Biotechnology...
BioCentury | Jan 19, 2004
Company News

Protein Design Labs, Seattle Genetics deal

...The companies expanded a 2001 antibody-drug conjugate (ADC) deal between SGEN and Eos Biotechnology, which was acquired...
Items per page:
1 - 10 of 77
BioCentury | Dec 20, 2010
Strategy

TAP's Big Finish

...for multiple undisclosed antigens Ended in 2006 Up to $30M up front and milestones 2001 Eos Biotechnology Inc....
BioCentury | Jul 23, 2007
Company News

Crucell management update

...SVP of R&D at CRXL's newly formed protein business unit, formerly chief technical officer at Eos Biotechnology Inc....
BioCentury | Jan 22, 2007
Strategy

Reset button

...his early promises. He had added biology expertise with the 2003 acquisition of antibody company Eos Biotechnology Inc....
BioCentury | Aug 29, 2005
Strategy

Tracking PDLI

...drops development of SMART anti-IL-12 antibody and Remitogen apolizumabC. 2/4/03 - Announces plans to acquire Eos Biotechnology...
BioCentury | Aug 29, 2005
Strategy

Thinking commercial

...in the hospital channel." McDade addressed the research gap in his first deal - acquiring Eos Biotechnology Inc....
BioCentury | Jun 27, 2005
Company News

Genentech, Protein Design Labs sales and marketing update

...milestones and royalties. Under a 2004 deal between Seattle Genetics Inc. (SGEN, Bothell, Wash.) and Eos Biotechnology...
BioCentury | Jan 31, 2005
Strategy

A NRDO exits

...still here. We are hoping to do the same with ESP." PDLI bought antibody company Eos Biotechnology Inc....
BioCentury | Sep 13, 2004
Company News

Arriva management update

...Robert Williamson as CEO, formerly an advisor to Arriva, and previously president and COO at Eos Biotechnology Inc....
BioCentury | Sep 9, 2004
Company News

Arriva names Williamson CEO

...most recently was an advisor to Arriva . Previously, he was president and COO at Eos Biotechnology...
BioCentury | Jan 19, 2004
Company News

Protein Design Labs, Seattle Genetics deal

...The companies expanded a 2001 antibody-drug conjugate (ADC) deal between SGEN and Eos Biotechnology, which was acquired...
Items per page:
1 - 10 of 77